188 related articles for article (PubMed ID: 29914829)
1. Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema.
Lerman M; Gaebler JA; Hoy S; Izhakoff J; Gullett L; Niecko T; Karaca-Mandic P; O'Donnell T; Rockson SG
J Vasc Surg; 2019 Feb; 69(2):571-580. PubMed ID: 29914829
[TBL] [Abstract][Full Text] [Related]
2. Assessment of quality of life changes in patients with lower extremity lymphedema using an advanced pneumatic compression device at home.
Maldonado TS; Rokosh RS; Padberg F; Rotella V; Miller H; Nassiri N; Jacobowitz G; Berland T; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):745-752. PubMed ID: 33137494
[TBL] [Abstract][Full Text] [Related]
3. Correlation of disease comorbidity with prescribed treatment among insured U.S. lymphedema patients.
O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MD
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):461-470. PubMed ID: 32470618
[TBL] [Abstract][Full Text] [Related]
4. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema.
Karaca-Mandic P; Hirsch AT; Rockson SG; Ridner SH
JAMA Dermatol; 2015 Nov; 151(11):1187-93. PubMed ID: 26444458
[TBL] [Abstract][Full Text] [Related]
5. US budget impact of increased payer adoption of the Flexitouch advanced pneumatic compression device in lymphedema patients with advanced chronic venous insufficiency and multiple infections.
Cohen A; Gaebler JA; Izhakoff J; Gullett L; Niecko T; O'Donnell T
J Med Econ; 2018 Oct; 21(10):993-1000. PubMed ID: 29975564
[TBL] [Abstract][Full Text] [Related]
6. A comparison of programmable and nonprogrammable compression devices for treatment of lymphoedema using an administrative health outcomes dataset.
Karaca-Mandic P; Hirsch AT; Rockson SG; Ridner SH
Br J Dermatol; 2017 Dec; 177(6):1699-1707. PubMed ID: 28573790
[TBL] [Abstract][Full Text] [Related]
7. Superior Clinical, Quality of Life, Functional, and Health Economic Outcomes with Pneumatic Compression Therapy for Lymphedema.
Desai SS; Shao M;
Ann Vasc Surg; 2020 Feb; 63():298-306. PubMed ID: 31629128
[TBL] [Abstract][Full Text] [Related]
8. Economic benefit of a novel dual-mode ambulatory compression device for treatment of chronic venous leg ulcers in a randomized clinical trial.
Marston WA; Kirsner RS; Tallis A; Hanft JR; Walters J; Farber A;
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1031-1040.e1. PubMed ID: 32451241
[TBL] [Abstract][Full Text] [Related]
9. Lymphedema-associated comorbidities and treatment gap.
Son A; O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MA
J Vasc Surg Venous Lymphat Disord; 2019 Sep; 7(5):724-730. PubMed ID: 31248833
[TBL] [Abstract][Full Text] [Related]
10. Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs.
Brayton KM; Hirsch AT; O Brien PJ; Cheville A; Karaca-Mandic P; Rockson SG
PLoS One; 2014; 9(12):e114597. PubMed ID: 25470383
[TBL] [Abstract][Full Text] [Related]
11. Phlebolymphemeda: usually unrecognized, often poorly treated.
Bunke N; Brown K; Bergan J
Perspect Vasc Surg Endovasc Ther; 2009 Jun; 21(2):65-8. PubMed ID: 19767404
[TBL] [Abstract][Full Text] [Related]
12. Patient-centered outcomes of a dual action pneumatic compression device in comparison to compression stockings for patients with chronic venous disease.
Lurie F; Schwartz M
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):699-706.e1. PubMed ID: 28818225
[TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema.
Ridner SH; Murphy B; Deng J; Kidd N; Galford E; Bonner C; Bond SM; Dietrich MS
Breast Cancer Res Treat; 2012 Jan; 131(1):147-58. PubMed ID: 21960113
[TBL] [Abstract][Full Text] [Related]
14. The clinical characteristics of lower extremity lymphedema in 440 patients.
Dean SM; Valenti E; Hock K; Leffler J; Compston A; Abraham WT
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):851-859. PubMed ID: 31992537
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
16. Pneumatic Compression Improves Quality of Life in Patients with Lower-Extremity Lymphedema.
Blumberg SN; Berland T; Rockman C; Mussa F; Brooks A; Cayne N; Maldonado T
Ann Vasc Surg; 2016 Jan; 30():40-4. PubMed ID: 26256706
[TBL] [Abstract][Full Text] [Related]
17. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
18. Real-Time Direct Evidence of the Superficial Lymphatic Drainage Effect of Intermittent Pneumatic Compression Treatment for Lower Limb Lymphedema.
Kitayama S; Maegawa J; Matsubara S; Kobayashi S; Mikami T; Hirotomi K; Kagimoto S
Lymphat Res Biol; 2017 Mar; 15(1):77-86. PubMed ID: 28323573
[TBL] [Abstract][Full Text] [Related]
19. The critical role of phlebolymphedema in cellulitis associated with lymphedema: Its incidence and economic impact in a large real-world population.
Tedesco A; O'Donnell T; Weycker D; Salehi P
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101704. PubMed ID: 37977518
[TBL] [Abstract][Full Text] [Related]
20. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases.
Fuldeore M; Yang H; Du EX; Soliman AM; Wu EQ; Winkel C
Fertil Steril; 2015 Jan; 103(1):163-71. PubMed ID: 25455535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
